News | June 17, 2021
Dr. Reddy's Laboratories asked to pay $462.5 mn to Hatchtech
The company is exploring all legal options to challenge the award.
The company is exploring all legal options to challenge the award.
It is expected that the drug substance would be available from August 2021 which will be supplied back to Bharat Biotech for producing COVAXIN
We focused on developing the product last year but now our focus is on ramping up our manufacturing capacity
Pharma industry is ready to embrace technology platforms with a keen focus on automation in manufacturing and digital health investment.
CLIRNET plans to expand globally and improve how medical knowledge is shared and used in practice
C-CAMP–Imperial College London partnership to boost biotech research, startup exchange, and translational innovation through a five-year collaboration
The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations
New regional hub strengthens presence in a key market and enhances service delivery for corporate healthcare clients
Move comes amid rising regulatory pressures
Subscribe To Our Newsletter & Stay Updated
